Iradimed Corp
- Last sale
- Nov 9, 2026 · +0.81%
- Market cap
- $1.11B
- 12.79M shares
- Filings
- 777
Q3 2026+14.4% FY25 yoy
Q3 2026+16.9% FY25 yoy
Q3 2026+19.0% FY25 yoy
Q3 2026derived−2.5% FY25 yoy
Q3 2026+16.7% FY25 yoy
Q3 2026−2.1% FY25 yoy
- $1.11B
- 46.4×
- 12.5×
- 10.4×
- 2.35%
- 1.46%
Twelve months to Sep 30, 2026 · derived
Price
Nov 9, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $83,814,000 | reported | |
| FY 2024 | 2024-12-31 | $73,242,000 | reported | |
| FY 2023 | 2023-12-31 | $65,562,296 | reported | |
| FY 2022 | 2022-12-31 | $53,303,145 | reported | |
| FY 2021 | 2021-12-31 | $41,814,581 | reported | |
| FY 2020 | 2020-12-31 | $31,717,372 | reported | |
| FY 2019 | 2019-12-31 | $38,517,141 | reported | |
| FY 2018 | 2018-12-31 | $30,438,983 revised | reported | |
| FY 2017 | 2017-12-31 | $23,081,592 | reported | |
| FY 2016 | 2016-12-31 | $32,496,548 | reported | |
| FY 2015 | 2015-12-31 | $31,593,720 | reported | |
| FY 2014 | 2014-12-31 | $15,653,057 | reported |
Capital returns
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2025 | $15.04M | — | $15.04M | — | 12.78M sh | +0.5% | 87.5% |
| FY2024 | $13.68M | — | $13.68M | — | 12.72M sh | +0.4% | 77.6% |
| FY2023 | $13.22M | — | $13.22M | $0.48 | 12.66M sh | +0.6% | 219.5% |
| FY2022 | $12.56M | — | $12.56M | — | 12.59M sh | +0.3% | 136.2% |
| FY2017 | — | $1.82M | $1.82M | — | 10.60M sh | −1.3% | 68.9% |
Segments
Geography
LineFY2025ShareChange
United States$70.56M84%+16.4%
International$13.26M16%+4.9%
International———
Total$83.81M
Surgical & medical instruments & apparatus
Iradimed Corp is the 54th largest of the 144 covered companies the SEC files under this code, by revenue. SIC 3841
CompanyRevenueGrowthNet marginMarket cap
NPCENeuroPace Inc$100.0M25.1%21.5%$425.9MKMTSKestra Medical Technologies, Ltd.$95.1M59.0%138.4%$1.7BLUNGPulmonx Corp$90.5M8.0%59.7%$130.9MDCTHDelcath Systems, Inc.$85.2M129.1%3.2%$743.1M
IRMDIradimed Corp (this company)$83.8M14.4%26.8%$1.1B
TELATELA Bio, Inc.$80.3M15.8%48.4%$38.0MPDEXPro DEX Inc$77.5M16.5%17.6%$225.5MSGHTSight Sciences, Inc.$77.4M3.1%49.7%$456.4MRCELAVITA Medical, Inc.$71.6M11.5%67.8%$507.1MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Iradimed Corp · CIK 1325618 · Engraved from SEC EDGAR